绿叶制药(02186.HK)抗抑郁1类创新药若欣林获批澳门上市

阿斯达克财经
07 Apr

绿叶制药(02186.HK) 公布,集团自主研发的1类创新药若欣林(盐酸托鲁地文拉法辛缓释川片)正式获得澳门药物监督管理局的上市批准,用于治疗抑郁症。若欣林是中国首个自主研发并拥有自主知识产权、用于治疗抑郁症的化药1类创新药。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-07 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10